Sarah Danson

基本信息

Career Trajectory

Bio

My clinical and research interests are in the treatment of melanoma and lung cancer, and in the early clinical assessment of new anticancer agents. Sheffield is an `Experimental Cancer Medicine Centre´ and its aims are to expand the early clinical trial portfolio and produce associated translational work. I am Sheffield ECMC Clinical Lead and chair of the national ECMC Strategy Group. I am NIHR National Speciality Lead for Cancer: Early Phase Trials. I am principal investigator on many early phase trials. I am Lead for the YCR CONNECTS fellowship programme.

Research Interests

Papers共 220 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A DNA Plasmid Melanoma Cancer Vaccine, SCIB1, Combined with Nivolumab Plus Ipilimumab in Patients with Advanced Unresectable Melanoma: Efficacy and Safety Results from the Open-Label Phase 2 SCOPE Trial

Heather May Shaw,Poulam M. Patel,Miranda Payne,Satish Kumar,Sarah Danson, Martin Highley, Kellati Prasad, Ruth Board, Clare Barlow,James Larkin,Kate Young, Amanda Fitzpatrick,Ioannis Karydis,Maria Marples, Rebecca Lee,Philippa Gail Corrie, Robert Miller, Georgia Goodhew, Fayaz Master, Lindy Durrant

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Abstract CT024: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label Phase 2 SCOPE Trial

Heather Shaw,Poulam Patel,Miranda Payne,Satish Kumar,Martin Highley, Kellati Prasad,Ruth Board, Clare Barlow,Sarah Danson, Robert Miller, Georgia Goodhew,Fayaz Master,Lindy Durrant

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

SELPAC: A 3 Arm Randomised Phase II Study of the MEK Inhibitor Selumetinib Alone or in Combination with Paclitaxel (PT) in Metastatic Uveal Melanoma (UM)

European journal of cancerpp.114009-114009, (2024)

Cited11Views0Bibtex

Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients

Hannah Gagg,Sophie T Williams,Samantha Conroy,Katie N Myers,Connor McGarrity-Cottrell,Callum Jones,Thomas Helleday,Juha Rantala,Ola Rominiyi,Sarah J Danson,Spencer J Collis,Greg Wells

F1000Research（2024）

Cited0Views0WOSBibtex

In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges

Md Marufur Rahman,Greg Wells,Juha K Rantala,Thomas Helleday,Munitta Muthana,Sarah J Danson

Expert review of clinical immunologyno. 8 (2024): 821-838

Cited0Views0WOSBibtex

Modi-1, Anti-Citrullinated Neoepitope Vaccine, Alone and Combined with Checkpoint Inhibitors in Patients with Head and Neck, Breast, Renal, and Ovarian Cancers: ModiFy Phase I/II Basket Clinical Trial-Report after Completion of Monotherapy Dose-Finding

Christian H. H. Ottensmeier,David J. James Pinato,Anne C. Armstrong,Stefan N. Symeonides,Poulam M. Patel,Sarah Danson,James Korolewicz,David Cameron, Robert M. Miller,Fayaz Master,Samantha Paston,Lindy G. Durrant

JOURNAL OF CLINICAL ONCOLOGY（2023）

Cited0Views0Bibtex

MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and Without RAS Mutations: Results of NLMT Arm J

G. Middleton,P. Fletcher,J. Savage, M. Mehmi,A. Greystoke, A. Dangoor,J. Cave,C. Escriu,P. Shaw,N. Steele,P. Jain,S. Popat,M. Forster,J. Spicer,N. Coupe,S. Danson,D. Gilligan,D. Muthukumar, G. Price,Y. Summers,E. Toy,L. Billingham

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S119-S120

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 220 篇Author StatisticsCo-AuthorSimilar Experts